Delivery Order SPE2DB20D9759-SPE2DB24FD5LH

Award Date 5/4/24
Potential Completion Date 5/24/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,837.40, is for the delivery of 4,562,331,276 Nexplanon 68 mg implants. This delivery order is issued under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which allows the DLA to order a comprehensive...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order worth $10,720.35 for the supply of Nexplanon 68 mg implants. The contract was awarded on June 27, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of July 19, 2024. This contract appears to be part of a larger indefinite delivery contract (IDC) valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business in Park Ridge, Illinois. The contract, with a ceiling value of $2,144.07, is for the delivery of Nexplanon 68 mg implants. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC allows the DLA to issue delivery orders for a wide...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order, with a firm fixed price pricing type, for the supply of 68 mg Nexplanon implants. The award has a ceiling value of $3,573.45 and a completion date of July 3, 2024. This contract is part of a larger indefinite delivery contract (IDC) with DMS...
The U.S. Defense Logistics Agency (DLA) awarded a $10,720.35 firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order was placed under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with DLA, valued at up to $499,999,999, that runs through December 31, 2025. The current delivery order is for the supply of Nexplanon 68 mg implants to support the...
This is a federal contract award from the U.S. Department of Defense's (DoD) Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $17,152.56, is for the delivery of Nexplanon 68 mg implants, a contraceptive product, to support the medical supply needs of military health facilities. The contract is a firm fixed-price delivery order under the DLA's SPE2DB indefinite delivery contract (IDC), which has...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $7,146.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Nexplanon 68 mg implants. This order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which allows the agency to issue delivery orders for a wide range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Nexplanon 68 mg implants, with a ceiling value of $3,573.45 and a completion date of July 16, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which allows the agency...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,720.35 contract is for the delivery of 4,565,067,184 Nexplanon 68 mg implants. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which allows the agency to issue delivery orders for a...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $35,734.50 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,564,068,971 Nexplanon 68 mg contraceptive implants. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, SPE2DB, that DMS Pharmaceutical Group holds with DLA, valued at up to $4,999,999 through the end of 2025. The IDV enables...
  • SPE2DB20D9759
    Indefinite Delivery Contract
  • SPE2DB20D9759-SPE2DB24FD5LH
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Nexplanon 68 mg implants, with a ceiling value of $10,720.35 and a completion date of May 24, 2024. The contract is a delivery order under a larger indefinite delivery contract (IDC) valued at up to $499,999,999, which allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. The contract has no set-aside designation.

Generated 8/3/24, 9:22 AM